The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance-Reference-Cited by-同舟云学术

The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance

Published:2019-02-11 Issue:22 Volume:38 Page:4412-4424
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Hepburn A. C.,Steele R. E.,Veeratterapillay R.,Wilson L.,Kounatidou E. E.,Barnard A.,Berry P.,Cassidy J. R.,Moad M.,El-Sherif A.,Gaughan L.,Mills I. G.,Robson C. N.^ORCID,Heer R.^ORCID

Funder

Prostate Cancer UK

Cancer Research UK

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0712-y.pdf

Reference60 articles.

1. Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176–87.

2. Navone NM, van Weerden WM, Vessella RL, Williams ED, Wang Y, Isaacs JT, et al. Movember GAP1 PDX project: an international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models. Prostate. 2018;78:1262–82.

3. van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161:933–45.

4. Korpal M, Korn JM, Gao X, Rakiec DP, Ruddy DA, Doshi S, et al. An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discov. 2013;3:1030–43.

5. Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen CC, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84–88.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cell mimicry for immune evasion and therapeutic resistance;Cell Stem Cell;2024-08

2. WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells;Journal of Experimental & Clinical Cancer Research;2024-07-23

3. In vivo targeted and deterministic single cell malignant transformation;2024-06-03

4. In vivo targeted and deterministic single cell malignant transformation;2024-06-03

5. CRISPR-RfxCas13d screening uncovers Bckdk as a post-translational regulator of the maternal-to-zygotic transition in teleosts;2024-05-23